This article provides a comprehensive overview of dynamic control strategies for optimizing biosynthetic reactor parameters, tailored for researchers, scientists, and drug development professionals.
This article provides a comprehensive overview of advanced strategies for optimizing cofactor recycling in enzymatic synthesis, a critical challenge in making biocatalysis economically viable for pharmaceutical production and biorefinery applications.
Toxicity from metabolic intermediates, proteins, or end-products presents a major barrier in microbial biosynthesis, impacting yields in biomanufacturing and influencing drug efficacy and side effects.
This article provides a comprehensive guide for researchers and drug development professionals tackling the persistent challenges in metabolic pathway flux balance analysis (FBA).
This article provides a comprehensive resource for researchers and drug development professionals on the directed evolution of biosynthetic enzymes.
This article provides a comprehensive analysis of product inhibition, a fundamental regulatory mechanism in enzymatic biosynthesis where the end product negatively feedback-inhibits its own synthesis, limiting metabolic yield.
This article provides a comprehensive overview of contemporary strategies for optimizing enzyme activity and substrate specificity, addressing critical needs in biomedical research and drug development.
This article explores the paradigm shift in chemical synthesis driven by high-throughput experimentation (HTE) and automation.
Foundation models, large-scale AI systems pre-trained on vast datasets, are revolutionizing materials science and drug development.
This article provides a comprehensive analysis of Ribosomally synthesized and post-translationally modified peptides (RiPPs) as versatile platforms for peptide engineering.